|
市場調查報告書
醫療相關法規最新趨勢：阿拉伯大公國
Healthcare Regulatory Update: The United Arab Emirates
| 出版商 |
Datamonitor |
| 出版日期 |
2010年01月 |
商品編碼 |
106709 |
| 內容資訊 |
英文 Pages: 44 |
| 價格 |
|
|
醫療相關法規最新趨勢：阿拉伯大公國 是由出版商Datamonitor在2010年01月所出版的。
這份英文市場調查報告書包含Pages: 44 價格從美金3800起跳。
本研究報告包括阿拉伯聯合大公國醫療制度概況、最新法規改革動向、阿布達比與杜拜之醫療改革動向以及兩方之差異，內容摘記如下。
第1章 研究摘要
第2章 阿拉伯聯合大公國之法規與商業動向
- 主要調査結果
- 國內已著手改善不平等的就醫人口與相關價格
- 學名藥製造商在價值鏈中扮演多樣化角色
- 阿布達比與杜拜之醫療改革概況
第3章 阿布達比之最新醫療改革法規動向
- 主要調査結果
- 為改變阿布達比醫療水準與就醫人數所需之策略
- 導入學名藥之後的法規干涉
- HAAD為減少未來藥物短缺所訂定的策略
- HAAD擴大Weqaya掃描程序包括follow-up測試以及乳房X光攝影
- 導入Thiqa程序的影響
- 醫療途徑的標準化
- 患者服從度的改善
- DAMAN限制劣等醫療的賠償
第4章 杜拜之最新醫療改革法規動向
- 主要調査結果
- 為改變杜拜醫療水準與就醫人數所需之策略
- 雖然民間之保險改革仍然落後，但公家機關的改革已開始實行
第5章 参考資料
附錄
圖表
Abstract
Introduction
The fragmented nature of the healthcare systems in the United Arab Emirates
remains despite the implementation of health reforms in the emirates of Abu
Dhabi and Dubai. The two major emirates are currently at different stages in
the development and implementation of reform with the gap between them in
terms of access to healthcare and pharmaceuticals widening, with Abu Dhabi
leading the way.
Scope of this research
- Insight into the inequality of healthcare access and associated costs
which has led to reform in the UAE
- Overview of the latest regulatory reforms in the UAE and their impact on
key stakeholders
- Update of strategies to improve healthcare standards and access in Abu
Dhabi
- Update of strategies to improve healthcare standards and access in Dubai
Research and analysis highlights
Healthcare reforms in the UAE have aimed to improve the accessibility and
quality of healthcare services available to residents while reducing the
burden of public financing of healthcare. Since 2009, a number of reforms have
been proposed and implemented, while others have been postponed in light of
the recent global economic downturn.
In Abu Dhabi, since the passing of the Health Insurance Bill in 2005, most
residents are now covered by health insurance, with this being justified by
increasing encounters between physicians and patients. The HAAD has also
implemented a number of cost saving strategies, a screening program for
nationals, and an eHealth platform.
In Dubai, the timelines for the proposed health insurance reforms have been
postponed. For expatriates, especially those on very low wages (such as
labourers), the postponement will mean that access to healthcare will remain
patchy, since they will have to pay out-of-pocket for treatment, or depend on
the goodwill of their employers.
Key reasons to purchase this research
- Understand the latest changes to the UAE healthcare market and the
strategic implications of current/ future reforms to your business
- Identify opportunities for mutually beneficial relationships between your
firm and other stakeholders
- Understand the latest commercial trends adopted in the healthcare industry
in response to, and in anticipation of the latest reforms
Table of Contents
EXECUTIVE SUMMARY
- Strategic scoping and focus
- Key findings
- Related reports
2. OVERVIEW OF REGULATORY AND COMMERCIAL TRENDS IN THE UAE
- Key findings
- Inequality of healthcare access and associated costs has led to reform in
the UAE
- High price of drugs in the UAE has contributed to high healthcare costs
and inequality to access
- Generic manufacturers diversify along the value chain
- Local generics manufacturers are transitioning towards innovative
manufacturing
- Local generics manufacturers have also been moving into distribution and
retail
- Overview of healthcare reforms in Abu Dhabi and Dubai
3. REGULATORY UPDATE OF HEALTHCARE REFORMS IN ABU DHABI
- Key findings
- Update of strategies to improve healthcare standards and access in Abu
Dhabi
- HAAD' s proposed pro-generic regulatory interventions
- Development of a positive formulary list for the basic health insurance
policy
- Diagnosis coding is expected to lead to the reduction of medical errors
- Rational drug use program cuts down unnecessary prescribing
- Compulsory prescription by molecular name
- The HAAD has developed a number of strategies to limit future drug
shortages
- The Ministry of Health has fast-tracked approval for the manufacturing
of vaccines locally for emergency use
- The HAAD is expanding the Weqaya screening program to include follow up
tests and mammograms
- Implications of the introduction of the Thiqa program
- Introduction of co-payments to the Thiqa program to prevent abuse
- Standardization of healthcare pathways
- Improving patient compliance
- DAMAN to block reimbursement for inferior medical treatment
4. REGULATORY UPDATE OF HEALTHCARE REFORMS IN DUBAI
- Key findings
- Update of strategies to improve healthcare standards and access in Dubai
- Expatriate private sector insurance reforms delayed, but public sector
reforms enacted
- The timelines for the implementation of the health insurance reforms in
Dubai have been postponed
- Implementation of health insurance program for public sector employees
- Launch of small-scale screening programs in Dubai
5. BIBLIOGRAPHY
- Contributing experts
- Datamonitor reports
- Publications and online articles
APPENDIX
TABLES
- Table: Trends in public and private sector healthcare facilities, Abu
Dhabi, 2007 - 08
- Table: Summary of the Enaya insurance plan in Dubai
- Table: Exchange rates, 2009
FIGURES
- Figure: The Health Authority of Abu Dhabi' s (HAAD) Unified Prescription
Form
- Figure: Impact of the HAAD' s pro-generic reforms in February 2009 on
consumption of brands in March 2009 in Abu Dhabi
- Figure: Flow-chart showing reasons for drug unavailability in Abu Dhabi,
2009
- Figure: The roll-out (Phase 1) and subsequent development of the Weqaya
program in Abu Dhabi, 2008 - 09
- Figure: The Health Authority of Abu Dhabi' s (HAAD) Public Health Priority
Matrix for Abu Dhabi, 2010
- Figure: Access to healthcare for nationals and expatriates at public and
private healthcare facilities in Dubai, 2009
|
